Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study Meeting Abstract


Authors: Cohen, A. D.; Zhou, P.; Reich, L.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
Abstract Title: Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study
Meeting Title: 46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 104
Issue: 11 Pt. 1
Meeting Dates: 2004 Dec 4-7
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2004-11-16
Start Page: 157A
End Page: 158A
Language: English
ACCESSION: WOS:000225127500545
PROVIDER: wos
PUBMED: 15562524
Notes: Meeting Abstract: 542 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos
MSK Authors
  1. Cyrus Hedvat
    123 Hedvat
  2. Julie T Feldstein
    288 Feldstein
  3. Adam D Cohen
    42 Cohen
  4. Raymond L Comenzo
    112 Comenzo
  5. Ping Zhou
    43 Zhou
  6. Martin Fleisher
    236 Fleisher
  7. Lilian M Reich
    66 Reich
  8. Daniel A Filippa
    98 Filippa
  9. Lisa A Drake
    8 Drake
  10. Alice M Ford
    1 Ford
Related MSK Work